PT1011720E - Respostas de linfocitos t citotoxicos nas mucosas - Google Patents
Respostas de linfocitos t citotoxicos nas mucosasInfo
- Publication number
- PT1011720E PT1011720E PT98946965T PT98946965T PT1011720E PT 1011720 E PT1011720 E PT 1011720E PT 98946965 T PT98946965 T PT 98946965T PT 98946965 T PT98946965 T PT 98946965T PT 1011720 E PT1011720 E PT 1011720E
- Authority
- PT
- Portugal
- Prior art keywords
- citotoxic
- mucoses
- lymphocytes
- responses
- mucosal
- Prior art date
Links
- 210000001744 T-lymphocyte Anatomy 0.000 title 1
- 231100000433 cytotoxic Toxicity 0.000 title 1
- 230000001472 cytotoxic effect Effects 0.000 title 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 abstract 1
- 230000006698 induction Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
- A61K2039/55538—IL-12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/023—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a poxvirus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5852397P | 1997-09-11 | 1997-09-11 | |
| US7489498P | 1998-02-17 | 1998-02-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1011720E true PT1011720E (pt) | 2005-04-29 |
Family
ID=26737711
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT98946965T PT1011720E (pt) | 1997-09-11 | 1998-09-11 | Respostas de linfocitos t citotoxicos nas mucosas |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1011720B1 (pt) |
| JP (1) | JP2001515869A (pt) |
| AT (1) | ATE285789T1 (pt) |
| AU (1) | AU757310B2 (pt) |
| CA (1) | CA2303410A1 (pt) |
| DE (1) | DE69828414T2 (pt) |
| ES (1) | ES2236941T3 (pt) |
| PT (1) | PT1011720E (pt) |
| WO (1) | WO1999012563A2 (pt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE281432T1 (de) | 1999-03-05 | 2004-11-15 | Univ Duke | C-16 ungesätigte fp-selektive prostaglandin analoge |
| ATE420657T1 (de) * | 1999-10-12 | 2009-01-15 | Ca Nat Research Council | Archaeosome als adjuvantien und träger für azelluläre impstoffe zur induktion einer zytotoxischen t-lymphozyten (ctl) immunantwort |
| US20020172693A1 (en) | 2000-03-31 | 2002-11-21 | Delong Michell Anthony | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
| US20020037914A1 (en) | 2000-03-31 | 2002-03-28 | Delong Mitchell Anthony | Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
| US20020013294A1 (en) | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
| US6368602B1 (en) * | 2000-06-16 | 2002-04-09 | Hadasit Medical Research Services And Development Ltd | Mucosal immunization against hepatitis A virus (HAV) through rectal administration of HAV vaccine |
| DE10154579A1 (de) * | 2001-11-07 | 2003-05-28 | Medigene Ag | Topikale Verwendung von Cytokinen und Chemokinen zur Behandlung von viralen oder mykotischen Hauterkrankungen oder Tumorerkrankungen |
| GB0224415D0 (en) * | 2002-10-21 | 2002-11-27 | Medical Res Council | Compositions |
| BRPI0504117A (pt) * | 2005-09-05 | 2007-05-22 | Fundacao De Amparo A Pesquisa | epìtopos, combinação de epìtopos, usos de epìtopos ou sua combinação, composição, usos da composição, vacinas profiláticas anti-hiv-1, vacinas terapêuticas, método para a identificação de epìtopos e métodos para o tratamento ou prevenção |
| WO2011003138A1 (en) * | 2009-07-06 | 2011-01-13 | The Australian National University | Immunomodulating compositions comprising interleukin 13 inhibitors and uses therefor |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6294322B1 (en) * | 1988-01-26 | 2001-09-25 | The United States Of America As Represented By The Department Of Health And Human Services | Multideterminant peptides that elicit helper T-lymphocyte cytotoxic T-lymphocyte and neutralizing antibody responses against HIV-1 |
-
1998
- 1998-09-11 PT PT98946965T patent/PT1011720E/pt unknown
- 1998-09-11 AT AT98946965T patent/ATE285789T1/de not_active IP Right Cessation
- 1998-09-11 WO PCT/US1998/019028 patent/WO1999012563A2/en not_active Ceased
- 1998-09-11 AU AU93862/98A patent/AU757310B2/en not_active Ceased
- 1998-09-11 JP JP2000510460A patent/JP2001515869A/ja active Pending
- 1998-09-11 EP EP98946965A patent/EP1011720B1/en not_active Expired - Lifetime
- 1998-09-11 CA CA002303410A patent/CA2303410A1/en not_active Abandoned
- 1998-09-11 ES ES98946965T patent/ES2236941T3/es not_active Expired - Lifetime
- 1998-09-11 DE DE69828414T patent/DE69828414T2/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2236941T3 (es) | 2005-07-16 |
| EP1011720B1 (en) | 2004-12-29 |
| WO1999012563A2 (en) | 1999-03-18 |
| ATE285789T1 (de) | 2005-01-15 |
| EP1011720A2 (en) | 2000-06-28 |
| AU9386298A (en) | 1999-03-29 |
| CA2303410A1 (en) | 1999-03-18 |
| AU757310B2 (en) | 2003-02-13 |
| WO1999012563A3 (en) | 1999-05-27 |
| DE69828414T2 (de) | 2005-12-01 |
| DE69828414D1 (de) | 2005-02-03 |
| JP2001515869A (ja) | 2001-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2110386T1 (es) | Conjugados de interferon. | |
| FI960631A0 (fi) | Termostabiilit ksylanaasit | |
| SE9602819D0 (sv) | Anordning för värmebehandling | |
| DE69828658D1 (de) | Breitbandiger optischer Verstärker mit gleichmässiger Verstärkung | |
| GB2299425A (en) | Specified return determinator | |
| NO904480D0 (no) | Varmeherdbare silisium-kompositter. | |
| DK0914116T3 (da) | Kompositstoffer omfattende konjugater af cis-docosahexaensyre og Taxotere | |
| BR9609812A (pt) | Para-herquamidas e marcfortinas antiparasíticas | |
| DE69528546D1 (de) | Breitbandiger Vorwärtskopplungsverstärker mit reduzierten Verzerrungen | |
| PT1011720E (pt) | Respostas de linfocitos t citotoxicos nas mucosas | |
| DK0780014T3 (da) | Sikkerhedsindretning | |
| TR199900505T2 (pt) | ||
| TR199700116A2 (tr) | Garnitürlerin taslanmasi icin cihaz ve yöntem. | |
| EP0674368A3 (en) | Semiconductor laser devices. | |
| ATE180350T1 (de) | Klemmeinrichtung und zugehörige halteeinrichtung | |
| DE59706706D1 (de) | Vorrichtung mit mindestens einer oberflächenschicht aus halbleitermaterial | |
| TR199802704T2 (xx) | H�V tedavisinde Vx478, Zidov�din, FTC ve/veya 3TC i�eren kombinasyonlar�n kullan�m�. | |
| DE59701095D1 (de) | Vakuumbeschichtungsanlage mit einer beschichtungskammer und zumindest einer quellenkammer | |
| ES1022967Y (es) | Calentador electrico por convenccion. | |
| MX9804043A (es) | Composiciones parasiticidas a base de polisiloxanos ciclicos. | |
| TR199700529A3 (tr) | Elektrik kenetleri. | |
| NL1000129A1 (nl) | Verwarmingsinrichting. | |
| NL1001408A1 (nl) | Werkwijze en inrichting voor het behandelen van een artikelbaan met vacuüm. | |
| ES1027890Y (es) | Pieza ceramica perfeccionada. | |
| ES1023689Y (es) | Calentador por induccion para el montaje de rodamientos, poleas objetos huecos y similares perfeccionado. |